Review of estrogen receptor, progesterone receptor, and HER-2/neu immunohistochemistry impacts on treatment for a small subset of breast cancer patients transferring care to another institution.
第一作者:
Julie M,Jorns
第一单位:
From the Departments of Pathology (Dr Jorns) and Biostatistics (Mr Healy and Dr Zhao), University of Michigan, Ann Arbor.
作者:
主题词
成年人(Adult);老年人(Aged);乳腺肿瘤(Breast Neoplasms);乳腺肿瘤, 男性(Breast Neoplasms, Male);癌, 导管, 乳腺(Carcinoma, Ductal, Breast);癌, 导管内, 非浸润性(Carcinoma, Intraductal, Noninfiltrating);雌激素受体α(Estrogen Receptor alpha);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);男(雄)性(Male);中年人(Middle Aged);病人转诊(Patient Transfer);受体, 孕酮(Receptors, Progesterone);转诊和会诊(Referral and Consultation);回顾性研究(Retrospective Studies)
DOI
10.5858/arpa.2012-0670-OA
PMID
24168506
发布时间
2022-03-17
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文